Edwards Lifesciences Corp (EW) revenue & profit
Edwards Lifesciences Corp (EW): revenue $6.1B, net income $1.1B in 2025; latest quarter +13.6% year over year. From SEC filings.
$6.1BRevenue 2025
TickerEW (NYSE)
IndustryHealthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Revenue 2025$6.1B
Net income 2025$1.1B
Net margin17.7%
Annual revenue growth+11.5%
Latest quarter (2026 Q2) · Revenue$1.7B
vs. same quarter last year+13.6%
Latest quarter · Net income$241.9M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $4.5B | $1.5B | |
| 2023 | $5B | $1.4B | |
| 2024 | $5.4B | $4.2B | |
| 2025 | $6.1B | $1.1B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.